Vulvar Inspection During Cervical Cancer Screening Procedures: The Ugly Reality.

IF 2.4 4区医学 Q2 OBSTETRICS & GYNECOLOGY

Journal of Lower Genital Tract Disease Pub Date : 2024-07-30 DOI:10.1097/LGT.0000000000000832

Mario Preti, Karin Anderson, Ezio Venturino, Tiziano Maggino, Francesca Carozzi, Eleonora Robba, Pedro Vieira-Baptista, Fulvio Borella, Laura Barchi, Federica Bevilacqua, Niccolò Gallio, Ilaria Barbierato, Benedetta Pollano, Camilla Cavallero, Samuel Gardner-Medwin, Chiara Benedetto, Lauro Bucchi

{"title":"Vulvar Inspection During Cervical Cancer Screening Procedures: The Ugly Reality.","authors":"Mario Preti, Karin Anderson, Ezio Venturino, Tiziano Maggino, Francesca Carozzi, Eleonora Robba, Pedro Vieira-Baptista, Fulvio Borella, Laura Barchi, Federica Bevilacqua, Niccolò Gallio, Ilaria Barbierato, Benedetta Pollano, Camilla Cavallero, Samuel Gardner-Medwin, Chiara Benedetto, Lauro Bucchi","doi":"10.1097/LGT.0000000000000832","DOIUrl":null,"url":null,"abstract":"<p><strong>Abstract: </strong>Vulvar examination during procedures for cervical carcinoma screening (CCS) can be a valid chance for early diagnosis of vulvar diseases and precancerous lesions. With this aim an online questionnaire was sent to the members of the Italian Cervical Carcinoma Screening Group (GISCi) from either first level group (FLG, Pap/human papillomavirus test sampling) or second level group (SLG, colposcopy and treatments) to assess if and how vulvar examination was performed. 86% of FLG and 90.2% of SLG report performing vulvar examination prior to CCS procedures. 15% of SLG cannot manage basic vulvar diseases and they refer patients to specialized center. 54.3% underline lack of standardized protocol in case of vulvar disease detection. Despite most health care professionals report examining the vulva during CCS procedures, vulvar cancer early diagnosis is still challenging.</p>","PeriodicalId":50160,"journal":{"name":"Journal of Lower Genital Tract Disease","volume":" ","pages":""},"PeriodicalIF":2.4000,"publicationDate":"2024-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Lower Genital Tract Disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/LGT.0000000000000832","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Abstract: Vulvar examination during procedures for cervical carcinoma screening (CCS) can be a valid chance for early diagnosis of vulvar diseases and precancerous lesions. With this aim an online questionnaire was sent to the members of the Italian Cervical Carcinoma Screening Group (GISCi) from either first level group (FLG, Pap/human papillomavirus test sampling) or second level group (SLG, colposcopy and treatments) to assess if and how vulvar examination was performed. 86% of FLG and 90.2% of SLG report performing vulvar examination prior to CCS procedures. 15% of SLG cannot manage basic vulvar diseases and they refer patients to specialized center. 54.3% underline lack of standardized protocol in case of vulvar disease detection. Despite most health care professionals report examining the vulva during CCS procedures, vulvar cancer early diagnosis is still challenging.

查看原文本刊更多论文

宫颈癌筛查过程中的外阴检查：丑陋的现实。

摘要：在宫颈癌筛查（CCS）过程中进行外阴检查是早期诊断外阴疾病和癌前病变的有效机会。为此，我们向意大利宫颈癌筛查小组（GISCi）的一级小组（FLG，巴氏/人乳头状瘤病毒检测采样）或二级小组（SLG，阴道镜检查和治疗）成员发送了一份在线问卷，以评估是否以及如何进行外阴检查。86%的FLG和90.2%的SLG报告在CCS手术前进行了外阴检查。15%的SLG无法处理基本的外阴疾病，他们会将患者转诊至专业中心。54.3%的SLG强调在检测外阴疾病时缺乏标准化方案。尽管大多数医护人员都表示会在CCS手术过程中检查外阴，但外阴癌的早期诊断仍具有挑战性。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Lower Genital Tract Disease OBSTETRICS & GYNECOLOGY-

CiteScore

6.80

自引率

8.10%

发文量

158

审稿时长

6-12 weeks

期刊介绍： The Journal of Lower Genital Tract Disease is the source for the latest science about benign and malignant conditions of the cervix, vagina, vulva, and anus. The Journal publishes peer-reviewed original research original research that addresses prevalence, causes, mechanisms, diagnosis, course, treatment, and prevention of lower genital tract disease. We publish clinical guidelines, position papers, cost-effectiveness analyses, narrative reviews, and systematic reviews, including meta-analyses. We also publish papers about research and reporting methods, opinions about controversial medical issues. Of particular note, we encourage material in any of the above mentioned categories that is related to improving patient care, avoiding medical errors, and comparative effectiveness research. We encourage publication of evidence-based guidelines, diagnostic and therapeutic algorithms, and decision aids. Original research and reviews may be sub-classified according to topic: cervix and HPV, vulva and vagina, perianal and anal, basic science, and education and learning. The scope and readership of the journal extend to several disciplines: gynecology, internal medicine, family practice, dermatology, physical therapy, pathology, sociology, psychology, anthropology, sex therapy, and pharmacology. The Journal of Lower Genital Tract Disease highlights needs for future research, and enhances health care. The Journal of Lower Genital Tract Disease is the official journal of the American Society for Colposcopy and Cervical Pathology, the International Society for the Study of Vulvovaginal Disease, and the International Federation of Cervical Pathology and Colposcopy, and sponsored by the Australian Society for Colposcopy and Cervical Pathology and the Society of Canadian Colposcopists.